HelpHelp About Us Contact Contact Us Help Help
Press Release Service
user name password
Client login:   
First time user sign up Forgot your login info?
Website Directory     Submit Website

Search
EmailWire News Links

Home > News By Company > ClassAction.org

Print e mail rss del Y! myWeb Tweet
 

Actos Lawsuit May Be Viable for Users Diagnosed with Bladder Cancer

Diagnosed with bladder cancer after taking Actos? Find out if you can file an Actos lawsuit by visiting ClassAction.org for a free case evaluation.

(EMAILWIRE.COM, January 25, 2012 ) New York, NY – An Actos lawsuit may be viable for users of the diabetes drug who were diagnosed with bladder cancer. Potentially, an Actos lawsuit could provide these individuals the chance to seek compensation for medical bills, lost wages, pain and suffering and other damages resulting from their diagnosis. Actos lawsuits must be filed within a certain amount of time, however, and failure to take legal action within this window will prevent the patient from ever seeking financial compensation for their condition. To find out if you can file an Actos lawsuit, visit http://www.classaction.org/actos.html for a free, no obligation case review.

A number of Actos lawsuits have already been filed on behalf of users who were diagnosed with bladder cancer in light of allegations that the manufacturer failed to warn consumers and doctors about this risk. In June 2011, the FDA announced in an Actos bladder cancer statement that use of the drug for longer than a year may be linked to an increased risk of developing cancerous tumors of the bladder. The agency advised the public of the potential Actos bladder cancer link after reviewing data from an ongoing, ten-year study of the drug. In light of this information, the FDA updated the diabetes drug’s label to reflect the Actos bladder cancer risk and to recommend that doctors should not use the drug in patients with active bladder cancer.

Because the manufacturer of Actos allegedly failed to warn patients and doctors about this risk, legal recourse may be available to users of the drug who were diagnosed with bladder cancer. If you or a loved one was diagnosed with bladder cancer after using Actos, visit Class Action.org to learn more about your eligibility for an Actos lawsuit. The Actos lawsuit attorneys working with the site are offering an online consultation at no cost and with no obligation.

About Class Action.org

Class Action.org is dedicated to protecting consumers and investors in class actions and complex litigation throughout the United States. Class Action.org keeps consumers informed about product alerts, recalls, and emerging litigation and helps them take action against the manufacturers of defective products, drugs, and medical devices. Information about consumer fraud issues and environmental hazards is also available on the site. Visit http://www.classaction.org today for a no cost, no obligation case evaluation and information about your consumer rights.

Contact Information:
ClassAction.org
Tara Nagel
Tel: 800-449-1970
Email us


This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International

Equityallianceir.com





Penny Stocks to Watch

Sign up for hot penny stock picks
Gains of 500%+ possible!

Premiumstockpicks.com/landing/




Satellite TV for PC

Watch Streaming Tv Right on Your PC

Satellitetelevisionforpc.com



 



Your text Ads & 

PR

Text Ads plus unlimited press releases, One release featured/Day for only $575 per month.

Read more on Text Ads & PR






Your text Ads Here!

Text Ads are only $289 per month. Ads are placed same day.

More on Text Ads Advertising




 

Search


Advertising | How to contact us | Privacy Statement | EmailWire Press Releases | Partnership Opportunities

EmailWire is a press release distribution service of GroupWeb Media LLC.

© Copyright GroupWeb Media LLC 2012